| Entry |
|
|---|
| Name |
Ilofotase alfa (USAN/INN) |
|---|
| Formula |
C4634H7226N1300O1429S36
|
|---|
| Exact mass |
105102.2674
|
|---|
| Mol weight |
105167.23
|
|---|
| Sequence |
VIPAEEENPA FWNRQAAEAL DAAKKLQPIQ KVAKNLILFL GDGLGVPTVT ATRILKGQKN
GKLGPETPLA MDRFPYLALS KTYNVDRQVP DSAATATAYL CGVKANFQTI GLSAAARFNQ
CNTTRGNEVI SVMNRAKQAG KSVGVVTTTR VQHASPAGTY AHTVNRNWYS DADMPASARQ
EGCQDIATQL ISNMDIDVIL GGGRKYMFPM GTPDPEYPAD ASQNGIRLDG KNLVQEWLAK
HQGAWYVWNR TELMQASLDQ SVTHLMGLFE PGDTKYEILR DPTLDPSLME MTEAALRLLS
RNPRGFYLFV EGGRIDHGHH EGVAYQAVTE AVMFDDAIER AGQLTSEEDT LTLVTADHSH
VFSFGGYPLR GSSIFGLAPG KARDRKAYTV LLYGNGPGYV LKDGARPDVT ESESGSPEYR
QQSAVPLDEE THGGEDVAVF ARGPQAHLVH GVQEQSFVAH VMAFAACLEP YTACDLALPA
CTTD
(Disulfide bridge: 121-183, 467-484, 481-481', 121'-183', 467'-484') |
|---|
| Type |
Peptide |
|---|
| Efficacy |
Enzyme replacement (intestinal alkaline phosphatase) |
|---|
| Type |
Enzyme replacement therapy product |
|---|
| Comment |
Treatment of sepsis-associated acute kidney injury
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Phosphatases
ALPI (IAP)
D12277 Ilofotase alfa (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
